NEW YORK (GenomeWeb News) – Hologic today named former Stryker executive Stephen MacMillan as its president and CEO, replacing Jack Cumming less than five months after Cumming returned for a second stint as head of the company.

MacMillan also was named to Hologic's board. Separately, the company also named Jonathan Christodoro and Samuel Merksamer, both of whom are managing directors at Icahn Capital, to its board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.